It has been shown that AKAP8 can inhibit the activity of the splicing factor and EMT-promoter heterogeneous nuclear ribonucleoprotein M (hnRNPM), thus inhibiting EMT and breast cancer metastasis in murine models. Here, AKAP8 is linked to breast cancer.